CD8A and cancer: In this paper, we summarize the current status and trends of the research on STING signaling pathway and cancer in the past 15 years, and it is clear that it can play an antitumor role in most cancers by activating the body's immune response with specific CD8(+) T cells, but there are less studies on its promotion in tumor progression.